Type 1 diabetes

Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study

Lancet Diabetes EndocrinolPublished Cross-sectional study

Authors' conclusion

In sub-Saharan Africa, clinically diagnosed type 1 diabetes is heterogeneous, comprising classic autoimmune type 1 diabetes and a novel, non-autoimmune, insulin-deficient diabetes subtype. There is evidence of this subtype in Black but not White individuals in the USA. Therefore, alternative causes must be considered in this group of individuals, and understanding the drivers of this subtype might offer new insights into prevention and treatment.

Study context

Population
Black African individuals without obesity with young-onset (age <30 years), insulin-treated, clinically diagnosed T1D, outpatient clinics in Cameroon, Uganda and South Africa; median age at diagnosis 15 years (IQR 11–19), median diabetes duration 5 years (2–10), BMI 21.7 kg/m² (19.5–24.1)1,072 identified
Participants
894 individuals
Exposure
Islet autoantibody-negative vs autoantibody-positive young-onset clinically diagnosed T1D
  • Autoantibody negativen = 582
  • Autoantibody positiven = 312reference
Outcome
Autoimmune origin of clinically diagnosed T1D: islet autoantibody positivity (GADA, IA-2A, ZnT8A), T1D genetic risk score and C-peptide
Methodological detailsobservational, multinational (Cameroon, Uganda, South Africa), comparison with SEARCH study (USA)
  • Observational
  • Multinational (Cameroon, Uganda, South Africa)
  • Comparison with SEARCH study (USA)

Main finding

As reported in the abstract

Islet autoantibody positivity (GADA, IA-2A, ZnT8A) and T1D genetic risk score (GRS)

Positive for islet autoantibodies

312 (34.9%) of 894

Without islet autoantibodies

582 [65.1%] of 894

Median T1D genetic risk score (GRS), without vs with autoantibodies (significantly lower without)

9.66 [IQR 7.77-11.33] vs 11.76 [10.49-12.91]

p<0.0001

Autoantibody-positive participants with plasma C-peptide <200 pmol/L

225 (82.7%) of 272

Observational data: associations, not effects.

Further findings

OutcomeValues
Autoantibody-negative diabetes, diagnosed <20 years: SEARCH Black ancestry vs sub-Saharan AfricaSEARCH Black 15.1% · median T1D GRS (autoantibody negative) 10.41 [IQR 8.65-12.22] · Sub-Saharan Africa 55.1%
Autoantibody negativity and T1D GRS in SEARCH White participantsSEARCH White 9.3% · median T1D GRS autoantibody negative 13.42 [IQR 11.80-14.61] · median T1D GRS autoantibody positive 13.49 [12.29-14.58]

Autoantibody negativity and T1D GRS in SEARCH White participants

Median GRS similar in autoantibody-negative and autoantibody-positive White participants

Original publication

Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study. Lancet Diabetes Endocrinol. Published 21 July 2025. doi:10.1016/s2213-8587(25)00120-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.